118 related articles for article (PubMed ID: 38426412)
1. Influence of
Li Y; Cui WW; Yang ZF; Liu WH; Bian MW; Deng J; Wang T
Chin Med Sci J; 2024 Mar; 39(1):9-18. PubMed ID: 38426412
[TBL] [Abstract][Full Text] [Related]
2. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
[TBL] [Abstract][Full Text] [Related]
3. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
4. Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.
Deng J; Fujimoto J; Ye XF; Men TY; Van Pelt CS; Chen YL; Lin XF; Kadara H; Tao Q; Lotan D; Lotan R
Cancer Prev Res (Phila); 2010 Apr; 3(4):424-37. PubMed ID: 20354164
[TBL] [Abstract][Full Text] [Related]
5. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
[TBL] [Abstract][Full Text] [Related]
6. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
7. Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A.
Mi L; Lei L; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J; Yin F
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766708
[TBL] [Abstract][Full Text] [Related]
8. Identification of Sca-1
Yin H; Jiang Z; Feng X; Ji Z; Jin W
Oncogene; 2020 Apr; 39(18):3754-3773. PubMed ID: 32157214
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
[TBL] [Abstract][Full Text] [Related]
10. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
[TBL] [Abstract][Full Text] [Related]
11. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.
Song H; Sun B; Liao Y; Xu D; Guo W; Wang T; Jing B; Hu M; Li K; Yao F; Deng J
Int J Cancer; 2019 Feb; 144(4):777-787. PubMed ID: 29992578
[TBL] [Abstract][Full Text] [Related]
12. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
[TBL] [Abstract][Full Text] [Related]
13. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
[TBL] [Abstract][Full Text] [Related]
14. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
15. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
[TBL] [Abstract][Full Text] [Related]
16. Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis.
Sun B; Guo W; Hu S; Yao F; Yu K; Xing J; Wang R; Song H; Liao Y; Wang T; Jiang P; Han B; Deng J
Oncotarget; 2017 Feb; 8(8):13532-13544. PubMed ID: 28088789
[TBL] [Abstract][Full Text] [Related]
17. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
[TBL] [Abstract][Full Text] [Related]
18. Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.
Guo W; Hu M; Wu J; Zhou A; Liao Y; Song H; Xu D; Kuang Y; Wang T; Jing B; Li K; Ling J; Wen D; Wu W
Biomed Pharmacother; 2019 Jun; 114():108791. PubMed ID: 30901718
[TBL] [Abstract][Full Text] [Related]
19. Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma.
Yin H; Jing B; Xu D; Guo W; Sun B; Zhang J; Liao Y; Song H; Wang T; Liu S; Kuang Y; Hu M; Li K; Zhang S; Zhang H; Xu J; Li X; Du J; Wu Y; Wu Y; Wang Q; Yao F; Chin YE; Zhou BP; Deng J
Cancer Res; 2022 Mar; 82(6):1025-1037. PubMed ID: 35045987
[TBL] [Abstract][Full Text] [Related]
20. GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Er J; Chao L; Yiwei L; Feng X; Fei Z; Kan W; Ruifei X
Exp Lung Res; 2020 Sep; 46(7):226-233. PubMed ID: 32410473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
